Market Overview:
Circulating tumor cells (CTCs) are cancer cells that have detached from the primary tumor and are circulating in the bloodstream. They can be used to detect and monitor metastatic disease. CTC analysis is a valuable tool for assessing prognosis, predicting response to therapy, and detecting recurrence of cancer. The global circulating tumor cells market is expected to grow at a CAGR of 10.5% from 2018 to 2030. The growth of this market is mainly driven by the increasing incidence of cancer, technological advancements in CTC detection methods, and growing demand for personalized medicine. However, high cost of diagnosis and treatment may restrain the growth of this market to some extent. The cell enrichment segment is expected to grow at the highest CAGR during the forecast period owing to increasing demand for targeted therapies and growing focus on precision medicine. By application, hospital segment dominates the global circulating tumor cells market due to rising number of patients with cancer worldwide coupled with increase in adoption rateof advanced diagnostic technologies such as liquid biopsy.
Product Definition:
Circulating tumor cells (CTCs) are cancer cells that have broken away from the primary tumor site and traveled through the blood or lymphatic system to other parts of the body. Cancer stem cells (CSCs) are a small population of cancer cells within a tumor that possess the ability to self-renew and generate new tumors. CTCs and CSCs play an important role in cancer metastasis, or spread, and can be used as biomarkers for early detection and prognosis.
Cell Enrichment:
Cell enrichment is a process to isolate and concentrate specific types of cells from the blood. It's majorly used for research purposes, but it has huge potential in the field of cancer treatment as well. Cell enrichment technique helps in increasing yield & purity, decreasing cell loss during purification procedure and also reduces cost by minimizing use of expensive antibodies & kits.
Cell Detection:
Cell detection and its usage in circulating tumor cells and cancer stem cells market is a technique used for the identification of cancer cell. It's major application includes breast, lung, colorectal, bladder, ovarian & prostate cancers.
Application Insights:
The market is segmented based on application into hospital, NSC and medical research institutes. The hospital segment dominated the global market in 2017 owing to increasing prevalence of cancer and rising demand for stem cell therapies. In addition, an increase in the number of hospitals offering clinical trials for CTCs has also positively influenced its growth. For instance, Hengrui Tumor Hospital & Institute provides personalized treatment through CTC therapy based on genetic analysis of tumor cells collected from patients suffering from lung, breast or colorectal cancer.
The National Stem Cell Research Institute (CNCRI) at Shenzhen was established by Shenzhen University with support from the Chinese government in 2014 as a national key laboratory dedicated to studying cancer stem cells (CSCs).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a strong network of cancer stem cell research institutes and hospitals, which is also a leading factor for CTCs research. The U.S.-based researchers have published over 1,000 papers on cancer stem cells in journals such as Cancer Cell, Stem Cells and Developmental Cell. Europe followed North America with more than 200 CCTC-related studies published in peer-reviewed journals since 2010 till 2016 (data obtained from Google Scholar).
Asia Pacific is expected to grow at the fastest rate during the forecast period owing to increasing government funding for stem cell therapy development along with growing awareness about these therapies among patients & physicians ( ). In September 2018, an international conference was held in Singapore focused on harnessing circulating tumor cells as a treatment modality for various cancers including leukemia and lymphoma ( ).
Growth Factors:
- Increasing incidence of cancer: The incidence of cancer is increasing at an alarming rate across the globe. This is primarily attributed to the changing lifestyle and dietary habits, growing pollution levels, and increasing aging population. This is expected to drive the demand for CTCs and CSCs over the forecast period.
- Growing awareness about early detection of cancer: There is a growing awareness among people about the importance of early detection of cancer. This has led to an increase in demand for tests that can detect tumor cells at an early stage such as CTC tests.
- Technological advancements in CTC and CSC detection methods: There has been a significant advancement in technology for detecting tumor cells over recent years. This has led to increased adoption of these methods, thereby driving the market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Circulating Tumor Cells and Cancer Stem Cells Market Research Report
By Type
Cell Enrichment, Cell Detection, CTC Analysis
By Application
Hospital, NSC, Medical Research Institute
By Companies
QIAGEN Hannover, AVIVA Biosciences, Epic Sciences, ApoCell, Cynvenio Biosystems, Fluxion Biosciences, Rarecells, Janssen Diagnostics, CellTraffix, Silicon Biosystems, Advanced Cell Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Circulating Tumor Cells and Cancer Stem Cells Market Report Segments:
The global Circulating Tumor Cells and Cancer Stem Cells market is segmented on the basis of:
Types
Cell Enrichment, Cell Detection, CTC Analysis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, NSC, Medical Research Institute
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- QIAGEN Hannover
- AVIVA Biosciences
- Epic Sciences
- ApoCell
- Cynvenio Biosystems
- Fluxion Biosciences
- Rarecells
- Janssen Diagnostics
- CellTraffix
- Silicon Biosystems
- Advanced Cell Diagnostics
Highlights of The Circulating Tumor Cells and Cancer Stem Cells Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell Enrichment
- Cell Detection
- CTC Analysis
- By Application:
- Hospital
- NSC
- Medical Research Institute
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Circulating Tumor Cells and Cancer Stem Cells Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Circulating tumor cells (CTCs) are cancer cells that have spread from the original site of the tumor to other parts of the body. CTCs can be found in blood, bone marrow, and other tissues. Cancer stem cells are a type of CTC that has the ability to divide and grow indefinitely. They may play a role in driving cancer growth and progression.
Some of the major players in the circulating tumor cells and cancer stem cells market are QIAGEN Hannover, AVIVA Biosciences, Epic Sciences, ApoCell, Cynvenio Biosystems, Fluxion Biosciences, Rarecells, Janssen Diagnostics, CellTraffix, Silicon Biosystems, Advanced Cell Diagnostics.
The circulating tumor cells and cancer stem cells market is expected to register a CAGR of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Circulating Tumor Cells and Cancer Stem Cells Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Circulating Tumor Cells and Cancer Stem Cells Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Circulating Tumor Cells and Cancer Stem Cells Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Circulating Tumor Cells and Cancer Stem Cells Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Circulating Tumor Cells and Cancer Stem Cells Market Size & Forecast, 2018-2028
4.5.1 Circulating Tumor Cells and Cancer Stem Cells Market Size and Y-o-Y Growth
4.5.2 Circulating Tumor Cells and Cancer Stem Cells Market Absolute $ Opportunity
Chapter 5 Global Circulating Tumor Cells and Cancer Stem Cells Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Type
5.2.1 Cell Enrichment
5.2.2 Cell Detection
5.2.3 CTC Analysis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Circulating Tumor Cells and Cancer Stem Cells Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 NSC
6.2.3 Medical Research Institute
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Circulating Tumor Cells and Cancer Stem Cells Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Circulating Tumor Cells and Cancer Stem Cells Analysis and Forecast
9.1 Introduction
9.2 North America Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Type
9.6.1 Cell Enrichment
9.6.2 Cell Detection
9.6.3 CTC Analysis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 NSC
9.10.3 Medical Research Institute
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Circulating Tumor Cells and Cancer Stem Cells Analysis and Forecast
10.1 Introduction
10.2 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Type
10.6.1 Cell Enrichment
10.6.2 Cell Detection
10.6.3 CTC Analysis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 NSC
10.10.3 Medical Research Institute
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Circulating Tumor Cells and Cancer Stem Cells Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Type
11.6.1 Cell Enrichment
11.6.2 Cell Detection
11.6.3 CTC Analysis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 NSC
11.10.3 Medical Research Institute
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Circulating Tumor Cells and Cancer Stem Cells Analysis and Forecast
12.1 Introduction
12.2 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Type
12.6.1 Cell Enrichment
12.6.2 Cell Detection
12.6.3 CTC Analysis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 NSC
12.10.3 Medical Research Institute
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Circulating Tumor Cells and Cancer Stem Cells Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Type
13.6.1 Cell Enrichment
13.6.2 Cell Detection
13.6.3 CTC Analysis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Circulating Tumor Cells and Cancer Stem Cells Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 NSC
13.10.3 Medical Research Institute
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Circulating Tumor Cells and Cancer Stem Cells Market: Competitive Dashboard
14.2 Global Circulating Tumor Cells and Cancer Stem Cells Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 QIAGEN Hannover
14.3.2 AVIVA Biosciences
14.3.3 Epic Sciences
14.3.4 ApoCell
14.3.5 Cynvenio Biosystems
14.3.6 Fluxion Biosciences
14.3.7 Rarecells
14.3.8 Janssen Diagnostics
14.3.9 CellTraffix
14.3.10 Silicon Biosystems
14.3.11 Advanced Cell Diagnostics
